drugset / Trial / NCT01992380

A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects

NCT01992380

Phase 1 Completed 24 enrolled Avid Radiopharmaceuticals
Non-randomizedParallel-groupSingle-blindDiagnostic

Summary

This study will test if two flortaucipir PET scans up to 4 weeks apart in healthy volunteers, MCI and AD subjects provide the same results.

Timeline

Start
2013-11-13
Primary completion
2014-05-30
Completion
2014-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Flortaucipir F18 Diagnostic / imaging agent 370 mbq Intravenous

Indications